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Objective: This study was done to determine whether etrograde delivery of 
cardioplegic solution provides uniform blood flow to the myocardium 
supplied by an occluded coronary artery and whether it maintains myocar- 
dial energy levels beyond the coronary occlusion. Methods: Isolated pig 
hearts were used. A hydraulic occluder was placed at the origin of the left 
anterior descending coronary artery. The perfusion pressure for retrograde 
delivery of cardioplegic solution was controlled at 40 to 50 mm Hg. 
Magnetic resonance imaging and localized 31p magnetic resonance spec- 
troscopy were used to assess myocardial perfusion and energy metabolism, 
respectively. Results: Magnetic resonance perfusion images (n = 7) showed 
that the perfusion defect that occurred during antegrade delivery of 
cardioplegic solution (as a result of the occlusion of the left anterior 
descending coronary artery) resolved during retrograde delivery of car- 
dioplegic solution. Retrograde perfusion delivered similar amounts of flow 
to the jeopardized myocardium as it did to other areas of the myocardium. 
However, the distribution of cardioplegic solution by the retrograde route 
was heterogeneous (cloudlike) across both ventricular walls. 3~p magnetic 
resonance spectra showed that the ischemic hanges induced by occlusion 
of the left anterior descending artery during antegrade perfusion were 
greatly alleviated by retrograde perfusion; however, it took longer for 
retrograde cardioplegia (n = 7, 17.08 minutes) to restore the levels of 
inorganic phosphate/phosphocreatine relative to the effect of releasing the 
left anterior descending artery occluder during antegrade delivery of 
cardioplegic solution (n = 7, 5.3 minutes). Conclusions: First, retrograde 
delivery of cardioplegic solution provides ufficient flow to the myocardium 
beyond a coronary occlusion to maintain near normal levels of energy 
metabolites, and second, the efficacy of the retrograde route of cardioplegic 
solution delivery (in terms of distribution of the solution and rate of myocar- 
dial energy recovery) is significantly lower than that of the antegrade route. 
(J Thorac Cardiovasc Surg 1997;114:109-16) 
A ntegrade cardioplegia has been extensively used to protect he heart during cardiac operations. 1-3 
In the presence of coronary arterial narrowing or 
occlusion, antegrade delivery of cardioplegic solu- 
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tion is compromised, leading to ischemic injury in 
the myocardium beyond the occluded coronary ar- 
teries. 4-6 Retrograde cardioplegia (with delivery of 
cardioplegic solution through the coronary sinus or 
the right atrium) has been used as an alternative to 
protect the jeopardized myocardium because coro- 
nary atherosclerosis (the most common cause of 
coronary arterial narrowing or occlusion) does not 
occur in the coronary venous system. 7-1° On the 
basis of the structure of the coronary system, the 
coronary arterial system is not necessarily the only 
outlet for retrograde perfusion.11-16 Retrograde per- 
fusion is expected to deliver media to the intramus- 
cular venous plexus and the capillaries in the 
myocardium supplied by an occluded coronary 
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artery. 11-16 At present, it is not clear whether etro- 
grade cardioplegic solution delivery provides suffi- 
cient flow to meet the energy requirements of the 
arrested myocardium nor is it known whether the 
distribution of solution by the retrograde method is 
homogeneous across the ventricular walls) 7-19 The 
present study was performed to assess the efficacy of 
retrograde delivery of cardioplegic solution to per- 
fuse the jeopardized myocardium and maintain 
myocardial energy levels. 
Myocardial perfusion during antegrade and retro- 
grade delivery of cardioplegic solution was assessed 
with the use of magnetic resonance (MR) perfusion 
imaging in conjunction with an extracellular MR 
contrast agent (gadolinium-diethylenetriamine pen-
taacetic acid [Gd-DTPA]). With use of this tech- 
nique, myocardial perfusion was visualized immedi- 
ately after injection of the contrast agent with 
relatively higher spatial and temporal resolutions 
compared to those obtained with conventional tech- 
niques, such as radioactive microspheres. The 
changes in cellular energetic metabolites (inorganic 
phosphate [Pi] and phosphocreatine [PCr]) during 
antegrade and retrograde cardioplegia in the myo- 
cardium beyond the arterial occlusion were moni- 
tored with localized 31p MR spectroscopy. 
Material and methods 
Isolated pig heart preparation. The pig was chosen as 
the animal model because the venous valves and the 
venous anastomoses in the pig heart are more similar to 
those of the human heart han those of the dog heart. 2°-22 
All animals received humane care in compliance with the 
"Guide to the Care and Use of Experimental Animals" 
(first edition) formulated by the Canadian Council on 
Animal Care. The protocols used in this study were 
approved by the Institute for Biodiagnostics Animal Care 
Committee. 
Domestic pigs weighing 45 to 60 kg were sedated with 
an intramuscular injection of diazepam (5 to 10 rag) and 
ketamine (25 rag). Anesthesia was maintained with 1% to 
2% isoflurane in a mixture of oxygen and nitrous oxide. 
The respiratory rate and volume were adjusted to keep 
the arterial blood gas values within the normal physiologic 
range. The brachiocephalic artery was cannulated at the 
level of the common carotid artery for arterial pressure 
monitoring, blood sampling, and infusion of cardioplegic 
solution. A sternotomy was performed. The brachioce- 
phalic and subclavian arteries were dissected. The peri- 
cardium was opened longitudinally along the midline. The 
ascending aorta and the main pulmonary artery were 
isolated by threading umbilical tape around the origin of 
the descending aorta. Anticoagulation was provided by 
injection of heparin (3000 IU) into the superior venae 
cavae. A cannula was inserted centrally in the brachioce- 
phalic artery. The brachiocephalic artery, subclavian ar- 
tery, descending aorta, and superior and inferior venae 
cavae were then clamped in succession. Heparinized cold 
(about 4 ° C) cardioplegic solution was infused into the 
aortic root (10 ml/kg body weight). The right and left atria 
were cut to allow drainage of the cardioplegic solution and 
to prevent warm blood in the lungs from returning to the 
heart. 
The heart was then excised. The brachiocephalic artery 
was joined to a cannula to be connected to a Langendorff 
perfusion apparatus. The subclavian artery was cannu- 
lated for measurement of antegrade perfusion pressure 
and drainage of blood cardioplegic solution during retro- 
grade perfusion. A hydraulic occluder was placed at the 
origin of the left anterior descending corornary artery 
(LAD). A retrograde cannula was positioned in the 
coronary sinus with a purse-string suture and over-and- 
over sutures to prevent solution leakage. With use of this 
technique we found that the posterior descending vein 
was well inflated or extended uring retrograde cardiople- 
gic solution delivery, which indicated good perfusion of 
this vessel. The hearts were then placed in the MR magnet 
and perfused in the Langendorff apparatus. 
Perfusion solutions. Pig hearts were arrested with a 
crystalloid cardioplegic solution containing (in millimoles 
per liter) NaC1 100, KC1 16, MgC12 16, ethylenedi- 
aminetetraacetic acid 0.5, glucose 11, NaHCO3 25, and 
CaC12 1.75 with bovine serum albumin 0.5%. The concen- 
tration of free calcium in this solution was 1.1 to 1.2 
mmol/L. 
For MR imaging studies, complete washout of the 
contrast agent before subsequent injection of agent is a 
prerequisite for accurate measurement of tissue perfu- 
sion. The amount of blood obtained from one pig was not 
sufficient o perform an imaging study. Thus the oxygen- 
ated crystalloid cardioplegic solution was used as the 
perfusion medium for the MR imaging study. 
For the transmural localized 31p MR spectroscopy 
studies, the pig hearts were perfused with a mixture of 
autogenous blood and the crystalloid cardioplegic solution 
(1:1, vol/vol) such that the hematocrit level was 12% to 
15% (the normal pig hematocrit s about 30%). 
All perfusion media were oxygenated and their pH was 
maintained at 7.4 to 7.5 (pH unit). The temperature of the 
heart was maintained at 36.5 ° to 37°C throughout the 
protocol. 
MR perfusion imaging. Tl-weighted MR imaging was 
performed with a 7 tesla 40 cm horizontal-bore magnet 
and a Helmholtz probe surrounding the whole heart. 
Tl-weighted images were acquired with an inversion- 
recovery gradient-echo sequence with a short repetition 
time (TR = 10 msec) and short echo time (TE = 4 msec). 
The inversion time (TI) and flip angle of the pulse were 
250 msec and 10 degrees, respectively. Each image cov- 
ered a 15 cm z field of view with 128 × 128 matrix size. 
Thus the size of each pixel was 1.17 mm 2. The perfusion 
images were acquired along the short axis of the heart. 
This orientation of the images provides the best view of 
myocardial perfusion throughout the heart with a single 
slice. Gd-DTPA (0.05 ml/kg body weight, Berlex Canada, 
Montreal, Canada) was used as the MR contrast agent. 
Time courses of the signal intensity of the perfusion 
images were generated by averaging the signal intensities 
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measured from the areas covering the LAD and the left 
circumflex perfusion beds. 
Transmural localized 31p MR spectroscopy. Trans- 
mural ocalized 31p MR spectroscopy was performed with 
the same magnet mentioned previously. For maximum 
sensitivity, a 2.5 cm diameter surface coil was placed on 
the anterior surface of the heart over the region perfused 
by the LAD. The magnetization was excited with use of an 
adiabatic pulse. This pulse can excite and invert the 
magnetization i the presence of large heterogeneity in 
the radio-frequency magnetic field and, therefore, is par- 
ticularly suitable for use with a surface coil. A two- 
dimensional column perpendicular tothe plane of the coil 
was selected with ISIS (image-selected in vivo spectros- 
copy) with an adiabatic inversion pulse. Localization in 
the third dimension along the two-dimensional column 
was achieved with the FLAX (Fourier-series-window, 
longitudinally modulated, and using adiabatic excitation) 
technique. 
The observed phosphorus compounds in the 31p spec- 
trum included Pi, phosphocreatine (PCr), and three peaks 
of adenosine triphosphate (ATP) (c~,/3, and 3, peaks). The 
signal intensity of these peaks is dependent on the dis- 
tance between the layer of the myocardium and the 
surface coil, and on the amount of the components in 
the layer examined. The signal intensity decreases as the 
distance between the myocardium from which the signal is 
acquired and the coil increases. It is not possible to 
compare the absolute value of the signal intensity between 
the various layers of the myocardium. 
In addition, the adiabatic pulse has a finite length and 
limited bandwidth. The transmitter frequency was set 
between the PCr peak and the Pi peak to achieve the 
maximum excitation of these two components. The 
/3-ATP peak is at approximately 18 ppm, or more than 2 
KHz (in a 7 tesla magnet) from the peak of PCr. The 
excitation of 13-ATP, therefore, was attenuated signifi- 
cantly. The amplitude of the/3-ATP peak in these exper- 
iments was considerably smaller than that observed when 
the /3-ATP is fully excited. Consequently, the actual 
changes in ATP levels may not be accurately measured by 
the changes in the/3-ATP peaks. Therefore, we did not 
use the /3-ATP peak to assess retrograde cardioplegia 
although all three peaks can be observed in the 31p 
spectra. On the other hand, because the Pi/PCr ratio is 
sensitive to ischemic insult and directly related to the 
cellular phosphorylation potential, this ratio was used to 
assess the effect of retrograde cardioplegia on myocardial 
energy metabolism. 
Because of the small percentage of the vascular space 
relative to the total tissue volume (approximately 5%) and 
the use of diluted blood, the 2,3-diphosphoglycerate peak 
is negligible when a spectrum is acquired from the myo- 
cardium. Therefore, the presence of 2,3-diphosphoglycer- 
ate did not significantly affect our measurement of Pi. 
Experimental protocol. The experimental protocols are 
summarized schematically in Fig. 1. 
MR imaging study. Pig hearts with intact LADs (n = 7) 
were perfused antegradely through the aorta for 30 min- 
utes with the oxygenated crystalloid cardioplegic solution, 
followed by 15 minutes of LAD occlusion with antegrade 
cardioplegia. The hearts were then subjected to retro- 
Protocol I 
Antegrade I Antegrade ]Retrograde ,,~ 
Open LAD Occluded LAD Occluded LAD 
Protocol n [ Transmural localized 31p MR spectroscopy [ 
Antegrade ] Antegrade [Retrograde 
Open LAD Occluded LAD Occluded LAD 
ProtocollII [ Transmural localized 3 ipMR spectroscopy [ 
Antegrade Antegrade Antegrade 
Open LAD Occluded LAD Open LAD 
i l  MR peffusion imaging 
Fig. 1. Schematic summary of the experimental proto- 
cols. 
grade cardioplegia for 30 minutes with the LAD occluded. 
The perfusion pressure for antegrade cardioplegic solu- 
tion administration was controlled at about 30 mm Hg to 
minimize myocardial edema. The coronary flow rate at 
this perfusion pressure was approximately 200 ml/min. It 
has been shown that the rate of myocardial oxygen 
consumption during arrest is approximately 1 ml/min per 
100 gm tissue. The average size of the pig hearts used in
this study was 250 gm. The total oxygen demand of the 
hearts was about 2.5 ml/min per heart. The oxygen content 
in the blood cardioplegic solution (a mixture of blood and 
crystalloid solution in a ratio of 1:1) after full oxygenation 
was about 7.2 ml/100 ml (about 5.4 ml oxygen carried by 
about 4 gm hemoglobin contained in the mixture and 
about 1.8 ml oxygen physically dissolved in the mixture). 
According to this calculation, the coronary flow at 30 mm 
Hg perfusion pressure was expected to deliver more 
oxygen than required by the heart. In addition, it has been 
shown that a pressure of 25 to 30 mm Hg during antegrade 
cardioplegic solution delivery is sufficient to maintain 
normal myocardial homeostasis. 23 
Coronary flow was reduced slightly after occlusion of 
the LAD to maintain a constant perfusion pressure. The 
perfusion pressure for retrograde delivery of cardioplegic 
solution was kept at 40 to 50 mm Hg according to 
recommendations i  the literature. 7 MR perfusion imag- 
ing was performed uring the three stages of the protocol. 31 Transmural localized P MR spectroscopy study. Pig 
hearts (n = 14) with a patent LAD were perfused 
antegradely for 20 minutes. The LAD was then occluded 
for 25 minutes to induce reversible myocardial ischemia. 
Again, the rate of coronary flow was reduced slightly (by 
10% to 20% of the previous levels) during occlusion of the 
LAD to maintain the perfusion pressure (30 mm Hg). 
After ischemia, seven hearts were subjected to retrograde 
perfusion at a perfusion pressure of 40 to 50 mm Hg with 
an occluded LAD and the other seven were maintained 
under antegrade perfusion and the occlusion was re- 
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Fig. 2. Representative Tl-weighted MR images obtained 
during antegrade (top panel) and retrograde (bottom 
panel) delivery of cardioplegic solution from a pig heart 
subjected to occlusion of the LAD. 
leased. The levels of energy metabolites in the region 
supplied by the LAD were monitored throughout the 
protocol. 
Statistical analyses. Statistical analyses were per- 
formed with STATISTICA software (STATSOFT Inc., 
Tulsa, Okla.). For 31p MR spectra, the peak areas were 
integrated to measure myocardial energy metabolites. 
Comparisons of Pi/PCr values between various layers of 
the myocardium were performed by a one-way analysis of 
variance. A significant change in the Pi/PCr levels induced 
by occlusion of the LAD and retrograde cardioplegia was 
determined by one-way analysis of variance. Comparison 
of the time courses of signal intensities of MR images 
obtained from the LAD region and the left ventricular 
free wall was performed by one-way analysis of variance 
with repeated measurements. 
Results 
Effect of retrograde cardioplegia on the perfusion 
deficit. The perfusion deficit induced by occlusion 
of the LAD during antegrade cardioplegia was 
reversed with retrograde cardioplegia. Fig. 2 shows 
representative MR images obtained during ante- 
grade (top panel) and retrograde (bottom panel) 
delivery of cardioplegic solution with an occluded 
LAD. During antegrade delivery of cardioplegic 
solution, the region of the myocardium supplied by 
the occluded LAD exhibited a perfusion deficit that 
was reversed uring retrograde cardioplegic solu- 
tion delivery in all seven hearts (7/7). Moreover, the 
distribution of myocardial perfusion was heteroge- 
neous (cloudlike) during retrograde delivery of car- 
dioplegic solution in all hearts (7/7). The distribu- 
tion of solution by retrograde perfusion in the 
various regions of the myocardium varied signifi- 
cantly from heart to heart. Moreover, there was no 
clear-cut edge between the high-intensity areas (per- 
fused areas) and "cold" spots (nonperfused areas) 
of the myocardium during retrograde cardioplegic 
solution delivery. 
Fig. 3 shows time courses of signal intensity 
obtained during antegrade (top panel) and retro- 
grade (bottom panel) delivery of cardioplegic solu- 
tion with occlusion f the LAD. During antegrade 
delivery of cardioplegic solution, the signal from the 
LAD region remained unchanged throughout the 
perfusion, which indicated essentially no perfusion 
to this area of the myocardium (p = 0.000). When 
retrograde delivery of cardioplegic solution was 
used, the myocardium supplied by the occluded 
LAD was perfused at the same flow rate relative to 
that in other regions of the left ventricular free wall 
(p = 0.252). Equal, but uneven, perfusion of solu- 
tion by the retrograde method in the myocardium 
supplied by the occluded LAD and other areas of 
the left ventricular wall was observed in all seven 
hearts. 
Effect of retrograde cardioplegia on myocardial 
energy metabolism. Fig. 4 shows the ratio of PifPCr 
obtained uring antegrade perfusion with the LAD 
open and occluded and during retrograde perfusion 
with the LAD occluded. The ratio of PifPCr during 
antegrade delivery of cardioplegic solution with an 
open LAD was 0.159 _+ 0.003 (n = 14). Occlusion of 
the LAD during antegrade cardioplegic solution 
delivery resulted in a significant increase in Pi/PCr 
(2.29 + 0.12, n = 14). The Pi/PCr ratios were not 
significantly different (p = 0.937) among the four 
layers of the myocardium during antegrade car- 
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Fig. 3. Time course of signal intensity of Tl-weighted 
MR images from the left ventricular (LV) free wall and 
the regions upplied by the LAD during antegrade (top 
panel) and retrograde (bottom panel) delivery of car- 
dioplegic solution (n = 7). 
dioplegic solution delivery with the LAD open or 
occluded. Retrograde cardioplegic solution deliv- 
ery with the LAD occluded resulted in a near 
complete return of Pi/PCr (0.23 + 0.006, n = 7) to 
preocclusion values. Although statistically signifi- 
cant (p = 0.018), the differences in Pi/PCr be- 
tween the corresponding layers of the myocar- 
dium during antegrade perfusion with an open 
LAD and retrograde perfusion with an occluded 
LAD were small. However, with retrograde deliv- 
ery of cardioplegic solution it took much longer 
(p = 0.000) for Pi/PCr values to return to normal 
than it did when the LAD occluder was released 
during antegrade delivery of cardioplegic solution 
(Fig. 5). Recovery of Pi/PCr values induced by 
release of the LAD occluder was usually complete 
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Fig. 4. Effect of retrograde cardioplegic solution delivery 
on myocardial energy levels. Measurements were ob- 
tained from the region supplied by the LAD. AO (ante- 
grade open), antegrade delivery of cardioplegic solution 
with intact LAD; AC (antegrade closed), antegrade car- 
dioplegic solution delivery with an occluded LAD; RC 
(retrograde closed), retrograde cardioplegic solution de- 
livery with an occluded LAD. The differences in Pi/PCr 
values between corresponding layers of the myocardium 
during the three stages of the protocol were statistically 
significant (/9 -- 0.00 for antegrade open vs. antegrade 
closed and for antegrade closed vs. retrograde closed; p = 
0.0186 for antegrade open vs. retrograde closed). 
and occurred within the period of the first MR 
spectrum (5.3 minutes). 
In addition, the coronary flow rate of retrograde 
cardioplegic solution delivery at a perfusion pres- 
sure of 40 to 50 mm Hg was 50 to 60 ml/min; 
generation of a similar perfusion pressure at the 
aorta during antegrade cardioplegic solution deliv- 
ery requires amuch higher coronary flow rate (>300 
ml/min), which suggests that the impedance of the 
coronary system is significantly higher during retro- 
grade perfusion than during antegrade perfusion. 
Discussion 
Perfusion of the heart hrough the coronary sinus 
was originally proposed by Pratt 24 in 1898. He used 
this approach to perfuse beating devascularized 
feline hearts and was able to maintain heart con- 
traction for up to 10 minutes. His work suggested 
that blood in the coronary vascular system can be 
made to flow in a direction opposite to the physio- 
logic direction. However, this unusual perfusion 
technique can maintain ormal heart function for 
only a short period. In 1956, Lillehei and associ- 
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Fig. 5. Recovery time of Pi/PCr obtained either by re- 
leasing the LAD occluder during antegrade delivery of 
cardioplegic solution r by retrograde delivery of car- 
dioplegic solution in the presence of LAD occlusion. The 
difference in the recovery time between the two groups 
was statistically significant (p = 0.000). 
ates 25 first used the technique to protect he human 
heart during cardiac operation. They perfused 
hearts with oxygenated blood to prevent myocardial 
injury and found that retrograde perfusion could not 
provide sufficient flow in the beating heart to main- 
tain normal myocardial energy metabolism. 
It has been gradually realized that the distribution 
of cardioplegic solutions to all regions of the heart is 
a prerequisite for optimal cardiac protection during 
heart operations. The presence of coronary obstruc- 
tion can disrupt the distribution of cardioplegic 
solution by the antegrade method. This leads to a 
significant reduction in the amount of cardioplegic 
solution that reaches the myocardium beyond the 
occluded coronary arteries. In aortic valve proce- 
dures, cardioplegic solutions are usually delivered 
by direct cannulation of both coronary ostia; how- 
ever, it was found that this route may occasionally 
lead to acute dissection or late ostial stenosis. 26 
Perfusion deficits in the jeopardized myocardium 
and during aortic root procedures and reoperative 
bypass procedures suggest that antegrade delivery of 
cardioplegic solution may not necessarily be the 
optimal strategy to protect the heart under all 
conditions. Because coronary atherosclerosis, which 
severely interrupts the even distribution of car- 
dioplegic solution by the antegrade method, does 
not occur in the coronary venous ystem, retrograde 
perfusion was revived in the 1980s. 9' 11 Although 
there are a number of studies that have assessed 
retrograde cardioplegia, its efficacy in maintaining 
the normal myocardial energy state has not been 
fully established. This study was done to determine 
whether retrograde cardioplegic solution delivery 
provides ufficient flow to the myocardium beyond a
coronary arterial occlusion to prevent ischemia. 
Under steady-state conditions, the reactions in- 
volving energy synthesis and consumption occur at 
the same rate. Although cardioplegic solution deliv- 
ered retrogradely may meet the energy requirement 
of the arrested heart, perfusion through the coro- 
nary sinus for long periods is expected to cause 
tissue edema that may compromise the oxygen 
supply, resulting in partial myocardial ischemia or 
anoxia. Thus it is difficult to determine whether any 
ischemic hanges that occur during retrograde car- 
dioplegia are a result of direct insufficiency of 
retrograde cardioplegic solution delivery or its side 
effect (edema). In the present study, a short period 
of ischemia induced by occlusion of the LAD during 
antegrade perfusion of cardioplegic solution was 
applied before the introduction of retrograde per- 
fusion. It was proposed that if retrograde cardiople- 
gia was able to meet myocardial energy require- 
ments under arrest conditions, the ischemic hanges 
would be expected to be reversed within a short 
period. Because the levels of Pi and PCr are more 
sensitive to ischemia than are the levels of ATP and 
the ratio of Pi/PCr is directly associated with cellular 
phosphorylation potential, 27 the efficacy of retro- 
grade cardioplegia was assessed using the ratio of 
Pi/PCr. 
This study demonstrated that the distribution of 
cardioplegic solution by retrograde perfusion is het- 
erogeneous (cloudlike) across the ventricular wall 
compared with that of solution delivered by the 
antegrade route. Patches of the myocardium in the 
left and right ventricular walls appear to receive no 
perfusion during retrograde delivery of cardioplegic 
solution. Moreover, there is no clear-cut edge be- 
tween well-perfused areas and nonperfused areas of 
the myocardium. Nevertheless, the perfusion deficit 
induced by occlusion of the LAD during antegrade 
delivery of cardioplegic solution (Fig. 2, top panel) 
disappeared during retrograde cardioplegic solution 
delivery. Moreover, the flow of cardioplegic solution 
delivered by the retrograde route to the occluded 
area was similar to that in the nonoccluded area of 
the myocardium (Fig. 3, bottom panel). Using an 
intravascular contrast agent (hydroxyethyl-starch- 
ferrioxamine), we found that the changes in signal 
intensity of Tl-weighted images induced by the 
agent were small because of the small percentage 
(about 5%) of intravascular space in the total tissue 
volume. 28 Conversely, the extracellular contrast 
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agent Gd-DTPA (freely distributed between vascu- 
lar and interstitial spaces) induced relatively large 
changes in signal intensity compared with those 
caused by hydroxyethyl-starch-ferrioxamine. 28 This 
greater increase in signal intensity induced by Gd- 
DTPA is expected to be mainly related to the 
contrast agent distributed in the interstitial space. In 
the present study, the myocardial perfusion images 
were obtained with use of Tl-weighted imaging in 
conjunction with Gd-DTPA. The distribution and 
perfusion kinetics of cardioplegic solution delivered 
via the retrograde route that were observed should 
be highly related to nutritive flow. 
In the present study, the efficacy of retrograde 
cardioplegia was further assessed using the Pi/PCr 
ratio. Occlusion of the LAD during antegrade de- 
livery of cardioplegic solution resulted in a signifi- 
cant increase in Pi/PCr values (from about 0.159 to 
about 2.29). Retrograde delivery of cardioplegic 
solution at 40 to 50 mm Hg perfusion pressure 
caused Pi/PCr to return to its preocclusion value 
(Fig. 4). These results suggest that retrograde car- 
dioplegic solution delivery provides ufficient flow to 
the myocardium beyond the occlusion of a coronary 
artery to maintain a near "normal" cellular energy 
state. We also found that it took much longer for 
retrograde cardioplegia to reestablish the preisch- 
emic value of Pi/PCr in the jeopardized myocardium 
than did releasing the LAD occluder during ante- 
grade delivery of cardioplegic solution (Fig. 5), 
which suggests that the oxygen delivery capacity of 
retrograde cardioplegia is significantly lower than 
that of antegrade cardioplegia under similar perfu- 
sion pressures (40 to 50 mm Hg and 30 mm Hg for 
retrograde and antegrade perfusion, respectively). 
From an energetics point of view, the results uggest 
that retrograde cardioplegia, under our experimen- 
tal conditions, allows energy production at a rate 
that is equal to or slightly greater than the rate of 
energy consumption. On the other hand, the energy 
supply with antegrade delivery of cardioplegic solu- 
tion (with significantly higher coronary flow) seems 
considerably higher than that required by the heart. 
Therefore it took less time for antegrade cardiople- 
gia to reestablish t e preischemic Pi/PCr value than 
it did for retrograde cardioplegia. More important, 
the results of this study suggest that a small increase 
in myocardial energy consumption (such as by ele- 
vating heart temperature) may cause an imbalance 
in the energy supply/demand ratio and lead to 
ischemia. This relatively lower capacity of retro- 
grade delivery of cardioplegic solution for myocar- 
dial perfusion relative to antegrade perfusion is 
likely to be related to its lower coronary flow rate. 
The effects of equal coronary flow of cardioplegic 
solution by antegrade and retrograde delivery on 
myocardial energy metabolism are still under inves- 
tigation in our laboratory. 
In summary, the retrograde method of cardiople- 
gic solution administration delivers olutions to the 
jeopardized myocardium. The patency of a coronary 
artery may not affect myocardial perfusion with 
retrograde delivery of the solution. Although its 
efficacy is significantly ower than that of antegrade 
delivery of cardioplegic solution, the retrograde 
method provides ufficient flow to prevent myocar- 
dial ischemia in arrested hearts. Because of its low 
efficacy of tissue perfusion and heterogeneous di - 
tribution, retrograde delivery of cardioplegic solu- 
tion should be used only when antegrade delivery of 
cardioplegic solution cannot reach all regions of the 
myocardium and cannot be performed adequately. 
One must realize that the period of ischemia in 
human beings may be longer than that in this study 
and that the delayed energy production resulting 
from retrograde perfusion may not be as useful as in 
this experiment. In addition, this experimental study 
dealt with acute coronary occlusion, which is rarely 
the case in human cardiac operations. Nevertheless, 
the combined benefits of antegrade/retrograde de- 
livery of cardioplegic solution have been established 
and it seems therefore that the combined use of 
antegrade/retrograde delivery of cardioplegic solu- 
tion (either sequentially or simultaneously) is war- 
ranted. 29 Future studies hould address the effects 
of temperature on the adequacy of protection of 
myocardial energy metabolism and the flow distri- 
bution of solution delivered by the antegrade and 
retrograde methods. Ideally, such work would be 
performed in a long-term model of myocardial 
ischemia that would better simulate the clinical 
situation than do acute measurements. 
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